Replies to post #151494 on Biotech Values

[DewDiligence]

AGN acquires MAPP for $25/sh in cash (60% premium):

http://finance.yahoo.com/news/allergan-inc-acquire-map-pharmaceuticals-013500252.html

The companies were partners on Levadex, an inhaled drug for acute treatment of migraine (#msg-59358620).